Prices delayed by at least 15 minutes | Print
Vaneck Ucits Etfs PLC VANECK BIONIC ENGINEERING UCITS ETF
Open
£17.518
Previous close
£17.48
Trade high
£17.518
Year low
£13.91
Year high
£18.36
Replication method
Physical Full
Volume
14
Type
ETF
UCITS
Yes
Dividend yield
-
Ongoing charge
0.55
ISIN
IE0005TF96I9
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Asset allocation
Top 10 holdings
Holdings 17/04/2024 | % of assets |
---|---|
DexCom Inc | 10.23 |
Edwards Lifesciences Corp | 10.09 |
Stryker Corp | 9.67 |
Medtronic PLC | 9.44 |
Zimmer Biomet Holdings Inc | 6.87 |
Cochlear Ltd | 4.44 |
Sonova Holding AG | 4.34 |
Inspire Medical Systems Inc | 3.79 |
Insulet Corp | 3.59 |
Straumann Holding AG | 3.59 |
Investment objective
The Fund’s investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to companies involved in the bionic implants industry including medical, dental, or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.
Asset class
ETFMorningstar ratingTM
Morningstar sustainability ratingTM
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.